Search research articles
Contact Us
Filters
Showing results (371-380 of 433) with videos related to
Page
of 44
Sort By:
Nuclear Medicine and Biology
|
June 10, 1998
Evaluation and metabolite studies of 125I- and 123I-labelled E-(R,R)-IQNP: potential radioligands for visualization of M1 muscarinic acetylcholine receptors in brain
K A Bergström, C Halldin, J Hiltunen, et al.
European Journal of Nuclear Medicine
|
June 1, 1997
Rhenium-188 hydroxyethylidene diphosphonate: a new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases
W Y Lin, C P Lin, S J Yeh, et al.
Nuclear Medicine and Biology
|
October 2, 2001
Efficacy of Re-188-labelled sulphur colloid on prolongation of survival time in melanoma-bearing animals
F D Chen, B T Hsieh, H E Wang, et al.
The Review of Scientific Instruments
|
May 2, 2023
A generalized approach to x-ray data modeling for high-energy-density plasma experiments
T Nagayama, M A Schaeuble, J R Fein, et al.
Brain Research
|
July 7, 2000
Hyperbaric oxygenation induced tolerance against focal cerebral ischemia in mice is strain dependent
K Prass, F Wiegand, P Schumann, et al.
The Journal of Biological Chemistry
|
April 18, 2002
DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis
Kimberly K Buhman, Steven J Smith, Scot J Stone, et al.
Stem Cell Reports
|
November 25, 2014
A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells
Philip A Beer, David J H F Knapp, Nagarajan Kannan, et al.
The Review of Scientific Instruments
|
May 3, 2014
Fusion-neutron-yield, activation measurements at the Z accelerator: design, analysis, and sensitivity
K D Hahn, G W Cooper, C L Ruiz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2003
Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate
Holger Palmedo, Agnieska Manka-Waluch, Peter Albers, et al.
European Journal of Nuclear Medicine
|
November 7, 1999
Iodine-123 labelled Z-(R,R)-IQNP: a potential radioligand for visualization of M(1 )and M(2) muscarinic acetylcholine receptors in Alzheimer's disease
K A Bergström, C Halldin, A Savonen, et al.
Page
of 44
Search research articles
Search
Showing results (371-380 of 433) with videos related to
Sort By:
Page
of 44
Nuclear Medicine and Biology
|
June 10, 1998
Evaluation and metabolite studies of 125I- and 123I-labelled E-(R,R)-IQNP: potential radioligands for visualization of M1 muscarinic acetylcholine receptors in brain
K A Bergström, C Halldin, J Hiltunen, et al.
European Journal of Nuclear Medicine
|
June 1, 1997
Rhenium-188 hydroxyethylidene diphosphonate: a new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases
W Y Lin, C P Lin, S J Yeh, et al.
Nuclear Medicine and Biology
|
October 2, 2001
Efficacy of Re-188-labelled sulphur colloid on prolongation of survival time in melanoma-bearing animals
F D Chen, B T Hsieh, H E Wang, et al.
The Review of Scientific Instruments
|
May 2, 2023
A generalized approach to x-ray data modeling for high-energy-density plasma experiments
T Nagayama, M A Schaeuble, J R Fein, et al.
Brain Research
|
July 7, 2000
Hyperbaric oxygenation induced tolerance against focal cerebral ischemia in mice is strain dependent
K Prass, F Wiegand, P Schumann, et al.
The Journal of Biological Chemistry
|
April 18, 2002
DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis
Kimberly K Buhman, Steven J Smith, Scot J Stone, et al.
Stem Cell Reports
|
November 25, 2014
A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells
Philip A Beer, David J H F Knapp, Nagarajan Kannan, et al.
The Review of Scientific Instruments
|
May 3, 2014
Fusion-neutron-yield, activation measurements at the Z accelerator: design, analysis, and sensitivity
K D Hahn, G W Cooper, C L Ruiz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2003
Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate
Holger Palmedo, Agnieska Manka-Waluch, Peter Albers, et al.
European Journal of Nuclear Medicine
|
November 7, 1999
Iodine-123 labelled Z-(R,R)-IQNP: a potential radioligand for visualization of M(1 )and M(2) muscarinic acetylcholine receptors in Alzheimer's disease
K A Bergström, C Halldin, A Savonen, et al.
Page
of 44